Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Beneficial action potential duration–shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2

EP Europace(2025)10.1093/europace/euaf168Source: DataRank Database

Beneficial action potential duration–shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2 is a research paper published in EP Europace (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (63)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Tibor Hornyik ORCID,Alicia de la Cruz ORCID,Irene Hiniesto‐Iñigo,Nicolò Alerni ORCID,Miriam Barbieri ORCID

Live enrichment

PubMed:40794559

NIH ROI

Grant: 2R01HL131461-05

European Union’s Horizon 2020

Grant: 850622

Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design

Swedish Research Council

Grant: (#2022-00844

Swedish Research Council

Grant: unidentified

unidentified

NHLBI NIH HHS

Grant: R01 HL131461

Bern Center of Precision Medicine Lighthouse

European Research Council

hybridLicense: cc-by-nc

publisherhttps://academic.oup.com/europace/advance-article-pdf/doi/10.1093/europace/euaf168/63960983/euaf168.pdf

publisherhttps://academic.oup.com/europace/article-pdf/27/9/euaf168/63960983/euaf168.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12454933

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12454933/

https://doi.org/10.1093/europace/euaf168

Fields of Study

0303 health sciences03 medical and health sciencesAnimalsLong QT SyndromeAction PotentialsRabbitsXenopus laevisMyocytes, CardiacHumansERG1 Potassium ChannelKCNQ1 Potassium ChannelGlycineDisease Models, AnimalInduced Pluripotent Stem CellsOocytesMyocardial ContractionHeart RateAnimals, Genetically ModifiedFemaleMutationLong Qt Syndrome 2

MeSH Terms

AnimalsLong QT SyndromeAction PotentialsRabbitsXenopus laevisMyocytes, CardiacHumansERG1 Potassium ChannelKCNQ1 Potassium ChannelGlycineDisease Models, AnimalInduced Pluripotent Stem CellsOocytesMyocardial ContractionHeart RateAnimals, Genetically ModifiedFemaleMutation

Keywords

ERG1 Potassium ChannelInduced Pluripotent Stem CellsGlycineAction PotentialsMyocardial ContractionAnimals, Genetically ModifiedLong QT SyndromeXenopus laevisDisease Models, AnimalHeart RateTranslational ResearchKCNQ1 Potassium ChannelMutationOocytesAnimalsHumansMyocytes, CardiacFemaleRabbitsAction potential durationDocosahexaenoyl glycineKCNQ1QT intervalRabbit model